18 research outputs found
Automatické systémy řízení technologických procesů provozu Koksovna Jan Šverma
Import 24/02/200
Native aortic valve thrombus as a source of embolisation into the coronary artery
AbstractAuthors present the case of 66-year-old patient after repeated systemic embolisations (lower extremity, axillary artery), admitted for inferior myocardial infarction. Coronary angiography demonstrated peripheral subtotal occlusion of posterior descending artery (PDA) of embolic origin. Transoesophageal echocardiography (TOE) revealed mobile mass on aortic valve, which was subsequently extirpated surgically. Histological examination described thrombus. Case report depicts the native aortic valve thrombus as a rare source of systemic or coronary embolisation. It simultaneously supports the indication of TOE at systemic embolisations of unknown source, even if transthoracic echocardiography (TTE) finding is normal, and shows its key role in diagnostic algorithm in similar events
Towards European Open Science Commons: The EGI Open Data Platform and the EGI DataHub
AbstractThis paper introduces the EGI Open Data Platform and the EGI DataHub, outlines their functionality and explains how this meets the requirements of EGI end users. The paper also explains how these new services can support the European Open Science Cloud and will fit into the future European Strategy Report on Research Infrastructures (ESFRI)
Safety of early discharge in low risk patients after acute ST-segment elevation myocardial infarction, treated with primary percutaneous coronary intervention. Open label, randomized trial
Early discharge (within 72h) in low risk patients after acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Single centre experience
AbstractWithin past decades the clear trend towards the shortening of the hospital stay in patients with myocardial infarction with ST segment elevations (STEMI) has been observed. The current Guidelines of European Society of Cardiology for the management of acute STEMI state, that in the selected patients may be considered early discharge (after approximately 72h), if adequate follow-up is arranged.Authors present prospective analysis of 25 low risk patients with STEMI, treated with successful primary percutaneous coronary intervention (PCI) and discharged within 48–72h after admission.Only 1 unplanned hospitalization for non-cardiac cause and no other serious complications were observed within 30-day follow-up.Presented data demonstrate that early discharge after STEMI in selected low risk patients is feasible and safe with regard to the conditions of regular clinical practice. This strategy applies to at least 14% patients with low risk of subsequent complications
EARLY DISCHARGE (48–72 HOURS) AFTER ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INTERIM RESULTS OF THE OPEN, RANDOMIZED, MONOCENTRIC STUDY
Authors present the interim analysis of open, prospective, randomized study, comparing the strategy of early (48–72 hours) and standard (after 72 hours) discharge in low risk patients after myocardial infarction with ST-segment elevation (STEMI), treated with successful primary percutaneous coronary intervention (PCI). 91 patients (22.5% of all STEMI patients admitted within the period between October 15, 2013 and October 6, 2015), who fulfilled given inclusion criteria of low risk, were randomly assigned to two groups in a 1:1 ratio. The primary end point was the composite of death, myocardial infarction (MI), unstable angina, stroke, unplanned rehospitalization, repeated target vessel revascularization, stent thrombosis within 90-day follow-up. The length of stay was significantly shorter in the intervention group (63.0 ± 7.8 h vs. 91.1 ± 11.9 h, p < 0.0001). The primary end point at 3 months occurred in 3 patients assigned to intervention group as compared to 2 patients assigned to control group (6.4% vs. 4.5%, p = 1.0 for non-inferiority). There were no significant differences in the incidence rates of individual components of the primary end point at 90 days. Presented interim data of the study support the claim that early discharge (48–72 hours) in selected patients after STEMI, treated with successful primary PCI, is possible and safe, with the results comparable to the later discharge, realized in compliance with current guidelines and present everyday clinical practice
